Study presented 77% of the treatment group recovered to a level of no symptoms or no significant disability on the modified Rankin Scale
BrainQ, the...
Abbott (NYSE:ABT) has halted a clinical trial comparing its HeartMate II ventricular assist device with the Abiomed (NSDQ:ABMD) Impella heart pumps.
The Abbott Park, Ill.-based company suspended enrollment...
New research published in the February issue of Journal of Wound Care (JWC) concludes the unique micro-anchor skin closure device known as BandGrip is more than five...
ZygoFix completed a $2 million round. Funds will support further clinical studies, enhancements to the company's implant and tools, and regulatory clearance.
ZygoFix's zLOCK™ is a...
Spineart USA Inc. announced that clinical principal investigator, Dr. Domagoj Coric at Carolina Neurosurgery and Spine Associates in Charlotte NC, performed the first surgery in the two-level U.S. Investigational...
Virta Health announced today that a study of its diabetes progression prevention treatment proved more effective than initially expected.
Peer-reviewed research in Nutrients highlighted the fact that only...
A randomized, controlled study published in JAMA Open found that patients who engaged in a virtual physical therapy program saw a greater reduction in...
In 2020, Appliedvr Inc. reported results from a three-week proof-of-concept study showing reduction of lower back pain with the use of its Easevrx virtual reality (VR)...
Gala Therapeutics, Inc. (Gala), a developer of medical devices to treat pulmonary disease, announces U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption...
